Aortic Dissection in a Patient Receiving Chemotherapy for Hodgkin's Disease

Abstract

Cancer chemotherapy is associated with a wide range of vascular toxicities, which may be related to endothelial cell damage by these agents. The authors describe a patient with Hodgkin's disease who developed an atypical aortic dissection while receiving MOPP/ABV chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine). They would place aortic dissection on the list of potential vascular complications associated with antineoplastic agents.

Get full access to this article

View all access options for this article.

References

Doll DC , Yarbro JW : Vascular toxicity associated with antineoplastic agents Semin Oncol 19:580-596, 1992.

Ergin MA , Griepp RB : Dissections of the aorta. In: Glenn's Thoracic and Cardiovascular Surgery , ed. 6, ed. by Baue AE. Stamford, CT: Appleton & Lange, 1996, pp 2273-2298.

Lazo JS : Endothelial injury caused by antineoplastic agents Biochem Pharmacol 35:1919-1923, 1986 .

Adamson Iyr , Bowden DH : The pathogenesis of bleomycin-induced pulmonary fibrosis in mice Am J Pathol 77:185-190, 1974.

Nicholson GL , Custead SE : Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity Cancer Res 45:331-334, 1985.